Eli Lilly and Company invests $4.5 billion in Indiana manufacturing capacity
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
What happened
Eli Lilly and Company announced a $4.5 billion investment in its facilities located in Indiana. This capital investment is intended to expand the company's manufacturing capacity for GLP-1 drugs.
From insidermonkey.com
Why it matters
The investment comes as Eli Lilly and Company continues to show strong financial growth, with Q2 revenue increasing 48% year over year to $23.0 billion. The company recently raised its full-year revenue guidance to $85 billion–$87 billion.
Eli Lilly's expansion in Indiana is driving local economic activity, benefiting from its proximity to Indianapolis.
From insidermonkey.com
Who's involved
- Eli Lilly and CompanyAnnouncing the $4.5 billion investment to expand manufacturing capacity.
- IndianaThe state of Indiana, which will host the expanded manufacturing facilities.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- IndianaSpeculative
Indiana might see increased jobs and tax revenue due to the capital investment.
How it developed
Newest first. Tap a step to see who reported it.Lilly is expanding manufacturing capacity for GLP-1 drugs.1 source
Lilly is investing $4.5B in Indiana facilities, alongside stock performance comparisons.1 source
Keep exploring
The entities involved
-
Eli Lilly and Company
American pharmaceutical company
-
Indiana
state of the United States of America